Oral medication using Tolvaptan for ADL of patients with acute congestive heart failure
Not Applicable
- Conditions
- acute heart failure
- Registration Number
- JPRN-UMIN000013091
- Lead Sponsor
- Tokyo Metropolitan Police Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
acute myocardial infarction severe respiratory failure (PaO2<60Torr, and/or SPO2<90% on oxygen administration) shock vital (sBP<90mmHg) serum sodium >146
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method activity of daily living (ADL), quality of life (QOL)
- Secondary Outcome Measures
Name Time Method Duration of hospitalization, place of discharge, cost